CTBP1 and colorectal carcinoma: It was also reported that miR-93-5p suppressed CRC progression via targeting PDL-1, and long non-coding RNA CTBP1-AS2 could modulate the miR-93-5P/TGF-beta/SMAD2/3 pathway in colorectal cancer [30,31].